Synergy CHC Corp.

SNYR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item May 2026 Mar 2026 Mar 2026 Dec 2025 Nov 2025 Sep 2025 Aug 2025 Jun 2025
Revenue $5.5M $8.0M $8.1M
Cost of Revenue $1.5M $2.3M $1.9M
Gross Profit $4.0M $5.7M $6.2M
Gross Margin 72.3% 70.9% 76.7%
Operating Expenses
Research & Development
SG&A Expense $2.0M $1.6M $1.5M
Operating Income $-567.1K $1.3M $1.6M
Operating Margin -10.3% 16.0% 20.0%
Interest Expense
Pretax Income $-2.6M $114.2K $1.7M
Income Tax Expense $-13.7K $-11.1K $190.1K
Net Income $-2.6M $125.3K $1.5M
Net Margin -46.8% 1.6% 18.1%
EPS (Basic) $-0.23 $0.01 $0.17
EPS (Diluted) $-0.23 $0.01 $0.17
Shares Outstanding (Basic) 14.9M 11.3M 11.3M 11.3M 11.3M 10.1M 9.4M 8.9M
Shares Outstanding (Diluted) 14.9M 11.3M 11.3M 11.3M 11.3M 10.1M 9.4M 8.9M
Dividends Per Share
← Newer Page 1 of 11 Older →